TRIANA Biomedicines
Phase 2TRIANA Biomedicines discovers and develops molecular glue therapeutics employing a target first and rational molecular glue discovery platform and focusing on degradation of high-profile cancer targets.
Founded
2008
Focus
Biologics
About
TRIANA Biomedicines discovers and develops molecular glue therapeutics employing a target first and rational molecular glue discovery platform and focusing on degradation of high-profile cancer targets.
Funding History
1Total raised: $110M
Series A$110MAtlas VentureJan 15, 2023
Company Info
TypePrivate
Founded2008
LocationCambridge, United States
StagePhase 2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile